(b).
Czech Republic | Estonia | Hungary | Italy | Latvia | Lithuania | |
---|---|---|---|---|---|---|
% difference originator vs. biosimilar price | ||||||
Launch of the biosimilar | 17.1% | 16.4% | 28.2% | Not recorded | Not applicable | 12.3% |
Latest difference | Similar | 7.1% | 1.6% | 31.6% | Not applicable | Similar |
% price change over time (from 2014/2015 to 2020) | ||||||
Originator | -25.5% | -24.9% | -21.2% | 52.3% | -14.4% | -21.1% |
Biosimilar | -7.7% | Stable | 1.2% | Not recorded | Not applicable | -6.8% |